Why India Failed to Penalize those Responsible for the Circulation of Substandard Medicines and Vaccines while China Succeeded?

Singh Br
Additional contact information
Singh Br: Division of Epidemiology, ICAR-IVRI, India

Global Journal of Pharmacy & Pharmaceutical Sciences, 2017, vol. 2, issue 5, 107-109

Abstract: The fake drug market is estimated at $200 billion by the World Customs Organization (WCO). The World Health Organization estimates that as many as 30% of all medicines sold in some areas of Asia are fake. Of those surveyed, as many as 67% considered counterfeit medicines were labeled dangerous [1]. Indian pharmaceutical companies suggested that in India’s major cities, one in every five strips of medicines sold is a fake leading to an annual revenue loss of 4-5%. It is also estimated that spurious drugs market growth are faster than the real drug market; it has grown from 10% to 20% of the total market.

Keywords: juniper publishers:Journal of Pharmacy; Global Journal of Pharmacy; Pharmaceutical Sciences; Pharmacy & Pharmaceutical Sciences; pharmaceutical sciences journals; omics online; open access; drug discovery; Clinical Trials; juniper publishers open access journals; juniper publishers reivew (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/gjpps/pdf/GJPPS.MS.ID.555599.pdf (application/pdf)
https://juniperpublishers.com/gjpps/GJPPS.MS.ID.555599.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jgjpps:v:2:y:2017:i:5:p:107-109

DOI: 10.19080/GJPPS.2017.02.555599

Access Statistics for this article

Global Journal of Pharmacy & Pharmaceutical Sciences is currently edited by Sophia Mathis

More articles in Global Journal of Pharmacy & Pharmaceutical Sciences from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().